Nataliya Melnyk

Nataliya Melnyk

UNVERIFIED PROFILE

Are you Nataliya Melnyk?   Register this Author

Register author
Nataliya Melnyk

Nataliya Melnyk

Publications by authors named "Nataliya Melnyk"

Are you Nataliya Melnyk?   Register this Author

21Publications

221Reads

-Profile Views

Evidence of both von Willebrand factor deposition and factor V deposition onto AL amyloid as the cause of a severe bleeding diathesis.

Blood Coagul Fibrinolysis 2017 Jun;28(4):342-347

aUniversity of Connecticut, Farmington, Connecticut bUniversity of Missouri, Columbia, Missouri cRobert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MBC.0000000000000600DOI Listing
June 2017

Frequent NFIB-associated Gene Rearrangement in Adenoid Cystic Carcinoma of the Vulva.

Int J Gynecol Pathol 2017 May;36(3):289-293

Department of Pathology (D.X., B.M.R.), The Johns Hopkins Medical Institutions, Baltimore, MDDepartment of Pathology and Laboratory Medicine (S.B., N.M., J.H., D.G.H., C.B.G., H.H.), University of British Columbia, Vancouver, BC, CanadaCellNetix Pathology (C.I.), Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000324DOI Listing
May 2017

Molecular characterization of a population-based series of endometrial stromal sarcomas in Kuwait.

Hum Pathol 2014 Dec 4;45(12):2453-62. Epub 2014 Sep 4.

Department of Laboratory Medicine and Pathology, University of Alberta and Royal Alexandra Hospital, Edmonton, AB T5H 3V9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2014.08.012DOI Listing
December 2014

TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data.

Genome Res 2014 Nov 24;24(11):1881-93. Epub 2014 Jul 24.

Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada; Department of Computer Science, University of British Columbia, Vancouver, BC V6T 1Z4, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 2B5, Canada;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/gr.180281.114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216928PMC
November 2014

Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.

Mod Pathol 2014 Jan 14;27(1):128-34. Epub 2013 Jun 14.

1] Department of Pathology and Laboratory Medicine, University of British Columbia, BC Cancer Agency, Centre for Translational and Applied Genomics, Vancouver, BC, Canada [2] Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915240PMC
January 2014

Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors.

Mod Pathol 2013 Jan 24;26(1):95-105. Epub 2012 Aug 24.

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2012.136DOI Listing
January 2013

Copy number aberrations in benign serous ovarian tumors: a case for reclassification?

Clin Cancer Res 2011 Dec 5;17(23):7273-82. Epub 2011 Oct 5.

Centre for Cancer Genomics and Predictive Medicine, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2080DOI Listing
December 2011

Frequency of known gene rearrangements in endometrial stromal tumors.

Am J Surg Pathol 2011 Sep;35(9):1364-72

Department of Pathology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00000478-201109000-000
Publisher Site
http://dx.doi.org/10.1097/PAS.0b013e3182262743DOI Listing
September 2011

ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway.

Cancer Res 2011 Feb 9;71(3):1060-70. Epub 2010 Dec 9.

Department of Molecular Oncology, BC Cancer Research Center, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-3096DOI Listing
February 2011

The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers.

Nat Med 2007 Sep 12;13(9):1060-9. Epub 2007 Aug 12.

Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Dr. Bohrgasse 3, 1030 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm1621DOI Listing
September 2007

Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney.

Hum Mol Genet 2004 Sep 14;13(18):2061-74. Epub 2004 Jul 14.

Department of Pathology, British Columbia Research Institute for Children's and Women's Health, University of British Columbia, Vancouver, BC, V5Z 4H4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddh215DOI Listing
September 2004